NO20005683L - Ny formulering inneholdende paroxetin - Google Patents

Ny formulering inneholdende paroxetin

Info

Publication number
NO20005683L
NO20005683L NO20005683A NO20005683A NO20005683L NO 20005683 L NO20005683 L NO 20005683L NO 20005683 A NO20005683 A NO 20005683A NO 20005683 A NO20005683 A NO 20005683A NO 20005683 L NO20005683 L NO 20005683L
Authority
NO
Norway
Prior art keywords
formulation containing
new formulation
containing paroxetine
paroxetine
hemihydrate
Prior art date
Application number
NO20005683A
Other languages
English (en)
Other versions
NO20005683D0 (no
Inventor
David Philip Elder
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20005683D0 publication Critical patent/NO20005683D0/no
Publication of NO20005683L publication Critical patent/NO20005683L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Paroxetinhydroklorid, i en annen form enn hemihydratet, som er benyttet i tabletter under betingelser som er slik at det ikke er noen påviselig omdannelse til hemihydrat under tabletteringsprosessen.
NO20005683A 1998-05-13 2000-11-10 Ny formulering inneholdende paroxetin NO20005683L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810181.9A GB9810181D0 (en) 1998-05-13 1998-05-13 Novel formulations
PCT/GB1999/001520 WO1999058113A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Publications (2)

Publication Number Publication Date
NO20005683D0 NO20005683D0 (no) 2000-11-10
NO20005683L true NO20005683L (no) 2000-12-05

Family

ID=10831927

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005683A NO20005683L (no) 1998-05-13 2000-11-10 Ny formulering inneholdende paroxetin

Country Status (20)

Country Link
EP (1) EP1077682A2 (no)
JP (1) JP2002514591A (no)
KR (1) KR20010043574A (no)
CN (1) CN1308521A (no)
AP (1) AP2000002019A0 (no)
AU (1) AU3940999A (no)
BG (1) BG105010A (no)
BR (1) BR9910401A (no)
CA (1) CA2331871A1 (no)
EA (1) EA200001174A1 (no)
GB (1) GB9810181D0 (no)
HU (1) HUP0102064A2 (no)
ID (1) ID28019A (no)
IL (1) IL139594A0 (no)
NO (1) NO20005683L (no)
PL (1) PL344573A1 (no)
SK (1) SK17142000A3 (no)
TR (1) TR200003350T2 (no)
WO (1) WO1999058113A2 (no)
ZA (1) ZA200006562B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
CA2464327A1 (en) * 2001-10-22 2003-05-30 Synthon B.V. N-formyl derivatives of paroxetine
GB2636182A (en) * 2023-12-04 2025-06-11 Novumgen Ltd An orally disintegrating tablet of paroxetine and its process of preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
HUP0000960A3 (en) * 1997-01-15 2001-04-28 Smithkline Beecham Plc Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same
HUP0100469A2 (hu) * 1997-12-19 2001-08-28 Smithkline Beecham Corporation Eljárás harapással diszpergálható tabletták előállítására

Also Published As

Publication number Publication date
AU3940999A (en) 1999-11-29
EA200001174A1 (ru) 2001-06-25
PL344573A1 (en) 2001-11-05
ZA200006562B (en) 2002-02-13
SK17142000A3 (sk) 2001-06-11
WO1999058113A2 (en) 1999-11-18
GB9810181D0 (en) 1998-07-08
EP1077682A2 (en) 2001-02-28
CA2331871A1 (en) 1999-11-18
CN1308521A (zh) 2001-08-15
HUP0102064A2 (hu) 2002-05-29
KR20010043574A (ko) 2001-05-25
NO20005683D0 (no) 2000-11-10
TR200003350T2 (tr) 2001-03-21
BR9910401A (pt) 2001-01-09
ID28019A (id) 2001-05-03
IL139594A0 (en) 2002-02-10
WO1999058113A3 (en) 2000-02-17
JP2002514591A (ja) 2002-05-21
AP2000002019A0 (en) 2000-12-31
BG105010A (en) 2001-07-31

Similar Documents

Publication Publication Date Title
SE9600071D0 (sv) New oral formulation of two active ingredients I
DK0841904T3 (da) Orale farmaceutiske præparater med forsinket frigivelse af reversible protonpumpeinhibitorer
NO20053106D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse.
DK1037634T3 (da) Oral administrationsform som omfatter en protonpumpeinhibitor (fx pantoprazo)
AR080436A2 (es) Preparacion solida de desintegracion rapida, uso de una hidroxipropilcelulosa poco sustituida en dicha preparcion y metodo para mejorar la desintegrabilidad oral de la misma
EE9700195A (et) Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja prokineetilist ainet
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
ATE223236T1 (de) Thyroxine/zyklodextrinkomplexe und ihre pharmazeutische formulierung
ES2137549T3 (es) Derivados antifungicos de sordaridina.
ATE311227T1 (de) Schnell-wirkende, gefrier-trocknete, orale, pharmazeutische formulierung für die behandlung von migräne
NO20060786L (no) Farmasoytiske preparater med oppsvulmbart belegg
NO20011217D0 (no) Doseringsform omfattende væskeformulering
DK1105105T3 (da) Oral administrationsform til pyridin-2-ylmethylsulfinyl-1H-benzimidazoler
ES2006170A6 (es) Procedimiento para preparar una composicion farmaceutica oral, de libe racion retardada a base de cetotifen.
SE9700885D0 (sv) New pharmaceutical formulation
YU45395A (sh) Novo hemijsko jedinjenje, njegovo pripremanje i njegova primena kao leka
NO20005683L (no) Ny formulering inneholdende paroxetin
AR042652A1 (es) Bromhidrato de escitalopram y un metodo para su preparacion
NO20005681L (no) Nye formuleringer som inneholder paroxetin
ES2148493T3 (es) Nuevos compuestos con efecto analgesico y anestesico local.
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
TR200200978T2 (tr) Yeni mirtazapin formülasyonu
KR890006236A (ko) 피페리디노 알칸올-충혈제거제 조합을 위한 약제학적 조성물
MX9703144A (es) Envase de seguridad frente a la accion de los niños para colocar parches portadores de principios activos.
ATE294773T1 (de) Substituierte 1- und 2-naphthol-mannichbasen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application